Arrowhead Pharmaceuticals (ARWR) has an average rating of buy and mean price target of $111.20, according to analysts polled by FactSet.
What else is happening in Research?
Research
Alantra Equities Downgrades CaixaBank to Neutral, Lifts PT
Alantra Equities on Monday downgraded Spanish lender CaixaBank (CABK.MC) to neutral from buy and increased the price target to 14.70 euros from 13.80 euros.
$CABK.MC
Research
Jefferies Upgrades Americana Restaurants International to Buy, Boosts PT
Jefferies on Monday upgraded restaurant operator Americana Restaurants International (ADX:AMR, SASE:6015) to buy from underperform and raised its price target to 2.96 Saudi riyals from 1.63 riyals.
ADX:AMRSASE:6015
Research
JP Morgan Starts Bytes Technology Coverage at Underweight
JP Morgan on Monday initiated coverage of software, security, artificial intelligence, and cloud services company Bytes Technology Group (BYIT.L, BYI.JO) with an underweight rating and a price target of 3.75 pounds sterling.
$BYI.JO$BYIT.L